AI assistant
Sending…
Sopharma AD — Earnings Release 2018
Jun 5, 2018
2543_rns_2018-06-05_11348eb2-79a3-4029-8648-b32073a4cfb3.pdf
Earnings Release
Open in viewerOpens in your device viewer
Current report No. 27/ 2018 Dated 5 June 2018
NOTIFICATION
Sopharma AD (the "Company") notifies that for May 2018 the Company recorded a decrease of sales revenues of 11% compared to the same month of 2017, including 1% increase of domestic sales and a decrease of 16% of export sales.
For the first five months of this year, revenues from sales of products decreased by 2% compared to the same period of 2017, including 1% increase of domestic sales and 3% decrease of export sales.
Signatures of individuals authorized to represent the Company:
Ognian Donev
More from Sopharma AD
Regulatory Filings
2026
May 29
Transaction in Own Shares
2026
May 29
Transaction in Own Shares
2026
May 28
Transaction in Own Shares
2026
May 27
Transaction in Own Shares
2026
May 26
Transaction in Own Shares
2026
May 22
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 21
Regulatory Filings
2026
May 20
Transaction in Own Shares
2026
May 19